MYDA Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,000
Closed -$738K 86
2018
Q3
$738K Buy
+6,000
New +$738K 0.4% 43